
India Pharma Outlook’s Pharma Services - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.
“Our vision is to help pharmaceutical companies’ derisk their supply chains by building reliable domestic manufacturing capabilities. By aligning customers with qualified Indian manufacturers and supporting product development, we are strengthening India's manufacturing ecosystem while creating more resilient and self-reliant supply chains” - Covenants PharmaChem
“By bringing scientific discipline to Ayurvedic drug discovery, Esslon is contributing to a broader movement that seeks to establish evidence based herbal therapeutics as credible additions to the global pharmaceutical landscape” - Esslon Pharma
“Rather than delivering recommendations in isolation, the firm works alongside leadership teams to strengthen decision-making processes, sharpen market positioning, enhance customer engagement strategies, and improve commercial execution” - Growth Magnet Advisory
“Rather than developing a generic business intelligence platform, Infisolve India chose to build...
| | Covenants Pharmachem | India has built one of the world's largest pharmaceutical manufacturing ecosystems, yet a significant portion of its approved manufacturing capacity remains underutilized. |
| | Esslon Pharma | Pharmaceutical research and development is undergoing a fundamental transformation. While synthetic molecules continue to dominate therapeutic innovation, there is growing global interest in scientifically validated natural medicines that combine traditional knowledge with modern drug development principles. |
| | Growth Magnet Advisory | The pharmaceutical industry has never been short of scientific innovation. What increasingly differentiates successful organizations today, however, is not the quality of their molecules alone, but the quality of their marketing intelligence. |
| | Infisolve India | As companies expand product portfolios, strengthen field operations, and compete in increasingly dynamic markets, the ability to convert commercial data into timely business decisions has become a defining competitive advantage. |
| | Moulins Pharmaceuticals | The pharmaceutical industry is often measured by famil¬iar metrics - market share, product portfolios, distribu¬tion reach, and manufacturing capabilities. |